Certificate PL-26-00127 · 5-Amino-1MQ 50 mg/mL Pen · lot PL-2610-004 · branded for Epic Wholesalers LLC -dba-Epic Peptides Lab
VerifyCertificate page
Epic Wholesalers LLC -dba-Epic Peptides Lab
Epic Wholesalers LLC -dba-Epic Peptides Lab
Certificate of Analysis · Lot release
www.epicpeptideslab.com
Certificate no.
PL-26-00127
Verification key
TFJEJK24
Scan or enter both at
prymalab.net/testing/verify

Certificate of Analysis · Lot release · Issued for Epic Wholesalers LLC -dba-Epic Peptides Lab

5-Amino-1MQ 50 mg/mL Pen

Lot PL-2610-004 · Solution · Label claim 50 mg/mL
Tested in-house by PrymaLab
In-house analytical result,
not an independent third-party test
Lot / batch number
PL-2610-004
Date made
2026-10-01
Date of analysis
2026-10-02
Date issued
2026-10-16
Retest / expiry
2028-10-01
Units in lot / sampled
276 / 2
Storage
—
Certificate type
Lot COA, 2 pages
Compound
5-Amino-1MQ
5-Amino-1-methylquinolinium iodide (NNMT inhibitor); small molecule, not a peptide
CAS number
42464-96-0
Molecular formula
C10H11N2·I (cation C10H11N2+)
Theoretical mass (avg.)
286.11 Da (iodide salt) · 159.09 Da (cation)
Structure
5-Amino-1-methylquinolinium iodide; the 159.09 Da cation is the species observed by ESI-MS
Purity · RP-HPLC, area %
99.75%
Specification ≥ 99.0% • main peak at 10.37 min
Identity · Observed Mass
159.10 Da
Theoretical cation 159.09 Da • +0.01 Da (63 ppm)
Overall conclusion
PASS
Meets every specification for the tests performed
TestMethodSpecificationResultConclusion
Identity (mass)LC-MS, ESI positiveTheoretical ± 1.0 Da159.10 DaPASS
PurityRP-HPLC, UV 254–306 nm, area%≥ 99.0%99.75%PASS
Largest impurityRP-HPLC, area%≤ 1.0%0.11% (RT 11.63)PASS
Assay (label claim)Assay vs label claim47.5–52.5 mg/mL50.38 mg/mLPASS
Bacterial endotoxinLAL, kinetic≤ 5.0 EU/mg0.360 EU/mgPASS
SterilityUSP <71>, 14-dayNo growthNo growthPASS

1HPLC chromatogram

Data file: PL-2610-004-HPLC.raw · Column C18, 150 × 4.6 mm · UV 254–306 nm
0.01%0.1%1%10%100%7891011121314Retention time (min) · stick height = area % (log scale)99.75% · 10.37 min0.04% †0.11% †0.10% †
Peak plot drawn from the integrated peak table (area %, log scale); it is not the instrument trace, which is retained in PL-2610-004-HPLC.raw. † Nominal reference retention time for the assigned impurity; the main-peak RT is observed in this lot.
Epic Wholesalers LLC -dba-Epic Peptides Lab
Epic Wholesalers LLC -dba-Epic Peptides Lab
Certificate of Analysis · continued
5-Amino-1MQ 50 mg/mL Pen · Lot PL-2610-004 · Certificate PL-26-00127
Lot PL-2610-004
Method, peak table and approval

2HPLC method · PL-2610-004-HPLC.raw

Instrument
Waters Alliance e2695
Data System
Empower 3
Detector
UV absorbance
Detection Wavelength
254–306 nm
Column
C18, 150 × 4.6 mm, 3.5 µm
Mobile Phase A
0.1% TFA in water
Mobile Phase B
0.1% TFA in MeCN
Gradient
5–95% B over 25 min (linear)
Flow Rate
1.0 mL/min
Column Temperature
40 °C
Injection Volume
10 µL

3Gradient program

Time (min)% A% B
0.0955
25.0595

4Peak table

PeakRT (min)AreaArea %
18.91 †—0.04
210.37—99.75
311.63 †—0.11
412.40 †—0.10
Total—100.00
Peaks: 1 related substance a; 2 main peak (5-Amino-1MQ); 3 related substance b; 4 related substance c · Area % from the integrated peak table (absolute areas are not part of the lot-release export) · † nominal reference RT for the assigned impurity · Purity = main peak area ÷ total integrated area × 100, to two decimals; main peak shaded.

5Identity by mass spectrometry

Instrument
Waters SQD
Ionization / Mode
ESI, positive
Reference m/z (ion)
159.09 [M]+
Deconvoluted Mass
159.10 Da
Theoretical Mass
159.09 Da (cation)
Difference
+0.01 Da (63 ppm)
Data File
PL-2610-004-MS.d
Acceptance
Within ± 1.0 Da

6Additional tests

TestPerformed byDateReport / file
Assay vs label claimPrymaLab Analytical2026-10-02—
Endotoxin (LAL, kinetic)PrymaLab Analytical2026-10-02—
Sterility (USP <71>, day-14 read-out)PrymaLab Analytical2026-10-16—
A test with no row here was not performed on this lot. Outside-laboratory reports, when used, are attached and named below.

7Review and approval

D. Reynolds
Analyst · performed the testing
Date: 2026-10-16
S. Calloway
Reviewer · checked against raw data
Date: 2026-10-16
M. Phelps
Lab Director · approved for release
Date: 2026-10-16